251 related articles for article (PubMed ID: 24978478)
1. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
Yang YL; Chen MW; Xian L
PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
[TBL] [Abstract][Full Text] [Related]
2. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.
He X; Chen Z; Jia M; Zhao X
PLoS One; 2013; 8(7):e70858. PubMed ID: 23923027
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis.
Chao D; Hu G; Li Q
Medicine (Baltimore); 2021 Feb; 100(7):e24748. PubMed ID: 33607820
[TBL] [Abstract][Full Text] [Related]
4. The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis.
Wu Y; Liu HB; Ding M; Liu JN; Zhan P; Fu XS; Lu G
Mol Biol Rep; 2012 Oct; 39(10):9621-8. PubMed ID: 22729914
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
Wang G; Ma W; Li Y; Jiang Y; Ma G; Zhang X; Meng L; Du J
Eur J Cardiothorac Surg; 2018 Aug; 54(2):237-245. PubMed ID: 29415155
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and potential drug target of T-cadherin in NSCLC.
Wang Z; Wang B; Guo H; Shi G; Hong X
Drug Des Devel Ther; 2015; 9():207-16. PubMed ID: 25565774
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
10. High expression of P-cadherin is significantly associated with poor prognosis in patients with non-small-cell lung cancer.
Imai S; Kobayashi M; Takasaki C; Ishibashi H; Okubo K
Lung Cancer; 2018 Apr; 118():13-19. PubMed ID: 29571991
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of E-cadherin in gastric cancer: a meta-analysis.
Xing X; Tang YB; Yuan G; Wang Y; Wang J; Yang Y; Chen M
Int J Cancer; 2013 Jun; 132(11):2589-96. PubMed ID: 23169395
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
14. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
Ci H; Xu Z; Xu J; Wang Y; Wu S
Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin in lung carcinoma, other than those with small cells (NSCLC).
Grigoraş ML; Arghirescu TS; Folescu R; Talpoş IC; Gîndac CM; Zamfir CL; Cornianu M; Anghel MD; Levai CM
Rom J Morphol Embryol; 2017; 58(4):1317-1325. PubMed ID: 29556623
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
